how often are glp 1 injections taken GLP-1 Administered? What Happens If You Stop

That being said, there is no significant clinical evidence to support its long-term safety, nor is it FDA-approved

Costly GLP-1 Drugs Are Rarely Covered for Weight Loss by Marketplace Plans

Expected Results (According to Clinical Trials) Retatrutide has generated significant scientific interest due to its robust efficacy signals in early clinical trials: Weight reduction: Clinical data have shown that patients receiving higher titration doses experienced substantial weight loss, in some cases exceeding 20% of baseline body weight over extended treatment periods

For patients with type 2 diabetes, hemoglobin A1c should be measured at baseline and approximately every 3 months until glycemic targets are achieved, then at least twice yearly if stable